Depomed (DEPO): 3 Near Term Drivers - RBC

RBC Capital analyst, Randall Stanicky, maintained his Sector Perform rating on shares of DepoMed Inc (NASDAQ: DEPO) but reviewed his model with management and sees 3 near term drivers for the stock. He does not anticipate upside with 2Q, however there are three important drivers to focus on (i) Starboard process with vote expected as early as late Sept (ii) Legal decision on NUCYNTA IR/ER by Sept 30 and (iii) P&L outlook with update coming with 2Q in early Aug.

No change to the price target of $22.

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $18.77 yesterday.

You May Also Be Interested In

• Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
• TD Cowen Reiterates Buy Rating on Broadcom Limited (AVGO), neutral into the print
• WaterBridge Infrastructure (WBI) PT Raised to $40 at Raymond James